Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Vosaroxin

EU orphan designation number: EU/3/12/990   
Active ingredient: Vosaroxin
Indication: Treatment of acute myeloid leukaemia
Sponsor: Sunesis Europe Ltd
19 Leyden Street, London E1 7LE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Orphan designation EMA/OD/158/11 (2012)2986 of 26/04/2012
01/12/2015 Change of name and/or address of sponsor